Figure 3.
Histone deacetylase (HDAC) inhibitors can normalize the quantitative abnormality in gene expression with p53‐mutated tumors, and can compensate for the inactivated p16 function by increasing the expression of the family genes.
Histone deacetylase (HDAC) inhibitors can normalize the quantitative abnormality in gene expression with p53‐mutated tumors, and can compensate for the inactivated p16 function by increasing the expression of the family genes.